INOVIO received regulatory authorization to conduct phase 3 efficacy trial of COVID-19 DNA vaccine candidate in Mexico
On Sept. 22, 2021, Inovio Pharmaceuticals announced that it had received authorization from COFEPRIS (Comisión Federal para la…
On Sept. 22, 2021, Inovio Pharmaceuticals announced that it had received authorization from COFEPRIS (Comisión Federal para la…
On Sept. 21, 2021, the Medicines Patent Pool (MPP) announced that it had signed a licence agreement with…
On Sept. 20, 2021, Pfizer and BioNTech announced results from a Phase 2/3 trial showing a favorable safety…
On Sept. 20, 2021, the University of Oxford and Oracle’s Global Pathogen Analysis System announced that it was…
On Sept. 17, 2021, six African lions, a Sumatran tiger and two Amur tigers tested presumptive positive at…
On Sept. 17, 2021, Zoo Atlanta reported that of the 20 gorillas at the Zoo, 18 showed clinical…
On Sept. 17, 2021, the Department of Defense (DOD), in coordination with the Department of Health and Human…
On Sept. 17, 2021, the Biden-Harris Administration announced a $2.1 billion investment to improve infection prevention and control…
On Sept. 17, 2021, Oxford’s Leverhulme Centre for Demographic Science reported the COVID-19 pandemic triggered life expectancy losses…
On Sept. 16, 2021, Moderna announced Health Canada had approved the New Drug Submission (NDS-CV) for SPIKEVAX (elasomeran…
On Sept. 16, 2021, as the COVAX Facility is forced to slash planned COVID-19 vaccine deliveries to Africa…
On Sept. 16, 2021, Novavax announced its participation in a newly expanded Phase 2 clinical trial called Comparing…
On Sept. 16, 2021, Celsion and Hainan Poly Pharm announced an amendment to their existing contract manufacturing agreement…
On Sept. 15, 2021, the National Institutes of Health (NIH) awarded nearly $470 million to build a national…
On Sept. 15, 2021, Guinea declared the end of the Marburg virus disease outbreak having recorded no new…
On Sept. 15, 2021, Oragenics announced the initiation of a study to evaluate the immunogenicity and viral load…
On Sept. 15, 2021, InBios announced that it had received Emergency Use Authorization from the U.S. Food and…
On Sept. 14, 2021, the World Health Organization (WHO) Director General Dr. Tedros Adhanom Ghebreyesus and a group…
On Sept. 14, 2021, Twist Bioscience announced that it had started shipping its synthetic RNA reference controls for…
On Sept. 14, 2021, Emergent BioSolutions and Providence Therapeutics announced they have entered into a five-year contract development…
On Sept. 14, 2021, the National Institutes of Health (NIH) announced that an international project called the COVID…
On Sept. 14, 2021, Regeneron announced an agreement with the U.S. Department of Health and Human Services and…
On Sept. 14, 2021, City of Hope announced that it had begun enrolling patients in a Phase 2…
On Sept. 14, 2021, the U.S. Department of Defense in coordination with the Department of Health and Human…
On Sept. 13, 2021, Twist Bioscience announced and Adicet Bio announced a collaboration to accelerate the discovery of…
On Sept. 10, 2021, Zoo Atlanta reported that it had received presumptive positive test results indicating that members…
On Sept. 10, 2021, the U.S. Department of Defense in coordination with the Department of Health and Human…
On Sept. 9, 2021, the National Institutes of Health (NIH) announced that it was providing approximately $185 million…
On Sept. 9, 2021, the University of Pennsylvania announced that the Breakthrough Prize in Life Sciences was awarded…
On Sept. 8, 2021, Bio-Techne and Carterra announced a clinical research collaboration studying COVID-19 variants. To assess immune…